[1]王 荣.诺和锐特充治疗妊娠期糖尿病的临床效果观察[J].医学信息,2018,31(08):186-187.[doi:10.3969/j.issn.1006-1959.2018.08.069]
 WANG Rong.Clinical Observation on the Treatment of Gestational Diabetes Mellitus with Novoterol[J].Journal of Medical Information,2018,31(08):186-187.[doi:10.3969/j.issn.1006-1959.2018.08.069]
点击复制

诺和锐特充治疗妊娠期糖尿病的临床效果观察()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
186-187
栏目:
出版日期:
2018-04-15

文章信息/Info

Title:
Clinical Observation on the Treatment of Gestational Diabetes Mellitus with Novoterol
文章编号:
1006-1959(2018)08-0186-02
作者:
王 荣
上海市静安区闸北中心医院妇产科,上海 200070
Author(s):
WANG Rong
Department of Obstetrics and Gynecology,Zhabei Central Hospital,Jing'an District,Shanghai 200070,China
关键词:
诺和锐特充妊娠期糖尿病血糖HOMA-IRHOMA-β
Keywords:
Key words:NovoterolGestational diabetes mellitusBlood sugarHOMA-IRHOMA-β
分类号:
R714.25
DOI:
10.3969/j.issn.1006-1959.2018.08.069
文献标志码:
B
摘要:
目的 探究在妊娠期糖尿病患者中采用诺和锐特充治疗的临床疗效。方法 选取我院2015年2月~2017年2月收治的妊娠期糖尿病患者84例,随机分为对照组41例和治疗组43例。对照组采用诺和灵R注射治疗,治疗组采用诺和锐特充治疗,比较两组患者的临床治疗效果和治疗前后的血糖变化情况。结果 治疗组治疗总有效率为95.35%,高于对照组的63.41%,差异具有统计学意义(P<0.05)。两组患者在治疗后血糖指标下降,其中治疗组的餐后2 h血糖和HOMA-IR下降程度高于对照组,HOMA-β的下降程度低于对照组,差异均具有统计学意义(P<0.05)。结论 采用诺和锐特充治疗妊娠期糖尿病患者,可以提高临床治疗效果,改善血糖变化情况,值得临床推广应用。
Abstract:
Abstract:Objective To investigate the clinical efficacy of Novoterol in the treatment of gestational diabetes mellitus.Methods 84 cases of gestational diabetes mellitus admitted in our hospital from February 2015 to February 2017 were randomly divided into control group(n=41)and treatment group(n=43).The control group was treated with Novolin R injection,and the treatment group was treated with Novoterol.The clinical effects and the changes of blood glucose before and after treatment were compared between the two groups.Results The total effective rate in the treatment group was 95.35%,which was higher than 63.41% in the control group,the difference was statistically significant(P<0.05).The blood glucose levels of the two groups decreased after treatment.The 2 hour postprandial blood glucose and HOMA-IR decreased in the treatment group was higher than that in the control group,and the decrease in HOMA-β was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion The treatment of gestational diabetes mellitus with Novoterol can improve the clinical therapeutic effect and improve the change of blood glucose.It is worthy of clinical application.

参考文献/References:

[1]关怀,尚丽新.妊娠期糖尿病流行现状[J].中国实用妇科与产科杂志,2015,31(1):91-94.
[2]曹慧兰,任雁林,王俊明,等.妊娠期糖尿病孕产妇的筛查、孕期管理与妊娠结局的相关性分析[J].河北医药,2015,37(4):507-509.
[3]曹萍.采用诺和锐特充治疗妊娠期糖尿病的临床效果及安全性评价[J].糖尿病新世界,2016,19(24):23-24.
[4]刘昊.论妊娠期糖尿病临床治疗体会及对分娩结局的影响研究[J].中外医疗,2014,33(5):73-74.
[5]杨晓彦,冀小平.妊娠期糖尿病的病因研究进展与相关高危因素[J].疾病监测与控制,2015,9(4):239-241.
[6]靳凤霞,任小平,陈丽丽.妊娠期糖尿病药物治疗进展[J].淮海医药,2016,34(4):502-503.
[7]裴晶晶,杨历波.诺和灵30R与诺和灵R联合诺和灵N治疗妊娠期糖尿病的疗效及依从性分析[J].现代诊断与治疗,2016,27(5):853-854.

相似文献/References:

[1]范新婷.层级护理在妊娠期糖尿病孕妇剖宫产中的应用研究[J].医学信息,2018,31(02):168.[doi:10.3969/j.issn.1006-1959.2018.02.065]
 FAN Xin-ting.Study on the Application of Hierarchical Nursing in Cesarean Section of Pregnant Women with Gestational Diabetes Mellitus[J].Journal of Medical Information,2018,31(08):168.[doi:10.3969/j.issn.1006-1959.2018.02.065]
[2]孟召然,李 玲,范建辉.妊娠期糖尿病相关危险因素分析[J].医学信息,2018,31(04):81.[doi:10.3969/j.issn.1006-1959.2018.04.026]
 MENG Zhao-ran,LI Ling,FAN Jian-hui.Analysis of Risk Factors Related to Gestational Diabetes Mellitus[J].Journal of Medical Information,2018,31(08):81.[doi:10.3969/j.issn.1006-1959.2018.04.026]
[3]李雪莲.妊娠合并糖尿病对分娩结局的影响观察[J].医学信息,2018,31(10):114.[doi:10.3969/j.issn.1006-1959.2018.10.036]
 LI Xue-lian.Effect of Pregnancy Complicated with Diabetes on Delivery Outcome[J].Journal of Medical Information,2018,31(08):114.[doi:10.3969/j.issn.1006-1959.2018.10.036]
[4]屈利洁.围生期综合护理措施及营养干预对妊娠期糖尿病患者的价值[J].医学信息,2018,31(15):171.[doi:10.3969/j.issn.1006-1959.2018.15.057]
 QU Li-jie.The Value of Perinatal Comprehensive Nursing Measures and Nutritional Intervention in Gestational Diabetes Patients[J].Journal of Medical Information,2018,31(08):171.[doi:10.3969/j.issn.1006-1959.2018.15.057]
[5]刘玉静,朱 静.产后护理管理对妊娠期糖尿病患者血糖控制及疾病认知水平的影响[J].医学信息,2018,31(23):180.[doi:10.3969/j.issn.1006-1959.2018.23.053]
 LIU Yu-jing,ZHU Jing.Effect of Postpartum Nursing Management on Blood Glucose Control and Disease Cognition of Gestational Diabetes Mellitus Patients[J].Journal of Medical Information,2018,31(08):180.[doi:10.3969/j.issn.1006-1959.2018.23.053]
[6]于素芳.妊娠期糖尿病的综合干预及药物治疗[J].医学信息,2019,32(01):59.[doi:10.3969/j.issn.1006-1959.2019.01.020]
 YU Su-fang.Comprehensive Intervention and Drug Therapy for Gestational Diabetes Mellitus[J].Journal of Medical Information,2019,32(08):59.[doi:10.3969/j.issn.1006-1959.2019.01.020]
[7]吴凌云.临床护理路径在妊娠期糖尿病合并妊娠期高血压患者中的应用[J].医学信息,2019,32(10):181.[doi:10.3969/j.issn.1006-1959.2019.10.061]
 WU Ling-yun.Application of Clinical Nursing Pathway in Gestational Diabetes Mellitus Complicated with Gestational Hypertension[J].Journal of Medical Information,2019,32(08):181.[doi:10.3969/j.issn.1006-1959.2019.10.061]
[8]左俊芳,刘沙沙,崔洪艳.妊娠期糖尿病高危因素及预防措施研究[J].医学信息,2022,35(17):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
 ZUO Jun-fang,LIU Sha-sha,CUI Hong-yan.Study on High Risk Factors and Preventive Measures of Gestational Diabetes Mellitus[J].Journal of Medical Information,2022,35(08):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
[9]王莎莎.孕期膳食指导改善血脂代谢预防妊娠期糖尿病与 妊娠高血压疾病的研究[J].医学信息,2019,32(18):89.[doi:10.3969/j.issn.1006-1959.2019.18.028]
 WANG Sha-sha.Dietary Guidance during Pregnancy Improves Blood Lipid Metabolism to Prevent Gestational Diabetes Mellitus and Pregnancy-induced Hypertension[J].Journal of Medical Information,2019,32(08):89.[doi:10.3969/j.issn.1006-1959.2019.18.028]
[10]陈锐聪,香钰婷,李仲均.妊娠期糖尿病孕妇血液中不同类型物质的代谢组学特点[J].医学信息,2023,36(19):185.[doi:10.3969/j.issn.1006-1959.2023.19.042]
 CHEN Rui-cong,XIANG Yu-ting,LI Zhong-jun.Metabolomics Characteristics of Different Types of Substances in the Blood of Pregnant Women with Gestational Diabetes Mellitus[J].Journal of Medical Information,2023,36(08):185.[doi:10.3969/j.issn.1006-1959.2023.19.042]

更新日期/Last Update: 2018-04-15